HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IgA-kappa type multiple myeloma affecting proximal and distal renal tubules.

Abstract
A 45-year-old male was admitted because of chest pain, lumbago, and bilateral ankle pain. Examination disclosed hypophosphatemic osteomalacia, acquired Fanconi syndrome, and abnormalities in distal nephron such as distal renal tubular acidosis and renal diabetes insipidus. Further exploration revealed IgA kappa multiple myeloma excreting urinary Bence Jones protein (kappa-light chain). Renal biopsy revealed thick basement membranes and elec-tron-dense crystals in proximal tubular epithelial cells. Immunofluorescent studies revealed deposition of kappa-light chain in renal tubular epithelial cells that caused the renal tubular damage. Although the osteomalacia was relieved by medical treatment, the urinary Bence Jones protein and the renal tubular defects were not improved by the chemotherapy for the myeloma. The patient died of exacerbation of multiple myeloma at 50 years of age.
AuthorsK Minemura, K Ichikawa, N Itoh, N Suzuki, M Hara, S Shigematsu, H Kobayashi, K Hiramatsu, K Hashizume
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 40 Issue 9 Pg. 931-5 (Sep 2001) ISSN: 0918-2918 [Print] Japan
PMID11579959 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulin A
  • Immunoglobulin kappa-Chains
Topics
  • Biopsy
  • Fatal Outcome
  • Humans
  • Immunoglobulin A
  • Immunoglobulin kappa-Chains
  • Kidney (metabolism, pathology)
  • Kidney Neoplasms (complications, diagnosis, metabolism, pathology)
  • Kidney Tubules, Distal (pathology)
  • Kidney Tubules, Proximal (pathology)
  • Male
  • Middle Aged
  • Multiple Myeloma (complications, diagnosis, metabolism, pathology)
  • Osteomalacia (etiology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: